F2RL1 and metabolic syndrome: In these studies, a case is made for the presence of sustained PAR2 mediated vasodilation in the diabetic, obese, or metabolic syndrome state that is consistent with the broader literature about preserved PAR2 functions on arterial vasculature, for example, in other models of circulatory diseases, conditions (ischemia), and injury [45, 51, 73–79].